Márta Venczel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Márta Venczel has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
Gabriella Ujhelyi
2 shared publications- Iria Torres-Terán
University of Greifswald. Department of Pharmacy, Institute of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport, 3 Felix Hausdorff Street, 17489 Greifswald, Germany; Sanofi-Aventis Deutschland GmbH, R&D, Global CMC Development, Synthetics Platform. Industriepark Hoechst, H770, D-65926 Frankfurt am Main, Germany
2 shared publications - Sandra Klein
Department of Pharmacy, University of Greifswald, 17489 Greifswald, Germany
2 shared publications - Adam J. S. McCartan
University of Bath, Department of Life Sciences, Claverton Down, UK
1 shared publication Alexander Marker
Sanofi-Aventis Deutschland GmbH, Frankfurt/Main,Germany
1 shared publicationAlla Kloss
Sanofi, R&D, Global CMC Development, Synthetics Platform, 350 Water Street, Cambridge, MA 02141, USA
1 shared publication
Latest Publications
- 9 September 2026
- Published by Springer Nature in The AAPS Journal
- Vol. 28 (5) , 144
In Vitro Release Testing for Long Acting Injectables – a Workshop Summary Report
A three-session webinar series was held by the IQ Consortium in early May 2023 on the topic of in vitro release testing of long acting injectable and paren
- 9 September 2026
- Published by Springer Nature in The AAPS Journal
- Vol. 28 (5) , 144
In Vitro Release Testing for Long Acting Injectables – a Workshop Summary Report
A three-session webinar series was held by the IQ Consortium in early May 2023 on the topic of in vitro release testing of long acting injectable and paren
- 21 November 2025
- Published by Elsevier in Journal of Controlled Release
- Vol. 389, 114401
Predicting human subcutaneous bioavailability of monoclonal antibodies using an open flow microperfusion porcine model
- 21 November 2025
- Published by Elsevier in Journal of Controlled Release
- Vol. 389, 114401
Predicting human subcutaneous bioavailability of monoclonal antibodies using an open flow microperfusion porcine model
- Open Access
- 13 May 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 658, 124227
Prediction of subcutaneous drug absorption − Development of novel simulated interstitial fluid media for predictive subcutaneous in vitro assays
- 13 May 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 658, 124227
Open AccessPrediction of subcutaneous drug absorption − Development of novel simulated interstitial fluid media for predictive subcutaneous in vitro assays
- 14 March 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 655, 123995
Biorelevant subcutaneous in vitro test predicts the release of human and fast acting insulin formulations
- 14 March 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 655, 123995
Biorelevant subcutaneous in vitro test predicts the release of human and fast acting insulin formulations
- Open Access
- 14 April 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 111 (9) , 2514-2524
Evaluation of In Vitro Tools to Predict the In Vivo Absorption of Biopharmaceuticals Following Subcutaneous Administration
- 14 April 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 111 (9) , 2514-2524
Open AccessEvaluation of In Vitro Tools to Predict the In Vivo Absorption of Biopharmaceuticals Following Subcutaneous Administration
- 1 January 2015
- Published by Dissolution Technologies in Dissolution Technologies
- Vol. 22 (3) , 26-31
Flow-Through Dissolution: A Useful Tool from Discovery Phase to Preclinical Development
- 1 January 2015
- Published by Dissolution Technologies in Dissolution Technologies
- Vol. 22 (3) , 26-31
Flow-Through Dissolution: A Useful Tool from Discovery Phase to Preclinical Development
- 22 July 2014
- Published by University of Szeged
Pharmaceutical development of co-crystals
- 10 February 2012
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 12 (3) , 1101-1110
Formulation Possibilities of a Weak Base with a Narrow Solubility Range
- 10 February 2012
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 12 (3) , 1101-1110
Formulation Possibilities of a Weak Base with a Narrow Solubility Range